Shangya Technology Co., Ltd. (TPEX:6130)

Market Cap	1.21B -24.1%
Revenue (ttm)	154.38M -22.0%
Net Income	-73.18M
EPS	-1.65
Shares Out	44.30M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	404,404
Open	27.40
Previous Close	27.40
Day's Range	26.90 - 28.45
52-Week Range	20.70 - 48.30
Beta	0.21
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 13, 2026

About Shangya Technology

Shangya Technology Co., Ltd. engages in the generic drugs and solar power generation businesses in Taiwan and Asia. The company wholesales Chinese and Western medicines, medical equipment, and beauty and hair care products; and onrito, lixin fumitation, lufuxing film-coated, amperex film coating, leverb-coated, triton film-coated, special core stabilized, tanlipo film-coated, inhibitory film-coated, yoyo flat mouth dissolved, and binlishu film-coated tablet, as well as pain relief capsules and yue shi tong injection. It is also involved in the ...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 1994
• Employees: 31
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 6130

Financial Performance

In 2025, Shangya Technology's revenue was 154.74 million, a decrease of -20.79% compared to the previous year's 195.35 million. Losses were -76.31 million, 128.3% more than in 2024.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Jul 16, 2026

Data Sources Report a data error